Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades

Abstract

IMPORTANCE Advances in childhood and adolescent cancer treatment have been associated with increased rates of cure during the past 3 decades; however, improvement in adult life expectancy for these individuals has not yet been reported.OBJECTIVES To project long-term survival and assess whether life expectancy will improve among adult survivors of childhood cancer who were treated in more recent decades. DESIGN, SETTING, AND PARTICIPANTSA microsimulation model of competing mortality risks was developed using data from the Childhood Cancer Survivor Study on 5-year survivors of childhood cancer diagnosed between 1970 and 1999. The model included (1) late recurrence, (2) treatment-related late effects (health-related [subsequent cancers, cardiac events, pulmonary conditions, and other] and external causes), and (3) US background mortality rates.EXPOSURES Treatment subgroups (no treatment or surgery only, chemotherapy alone, radiotherapy alone, and radiotherapy with chemotherapy) and individuals with acute lymphoblastic leukemia during childhood by era (1970-1979, 1980-1989, and 1990-1999).MAIN OUTCOMES AND MEASURES Conditional life expectancy (defined as the number of years a 5-year survivor can expect to live), cumulative cause-specific mortality risk, and 10-year mortality risks conditional on attaining ages of 30, 40, 50, and 60 years. RESULTS Among the hypothetical cohort of 5-year survivors of childhood cancer representative of the Childhood Cancer Survivor Study participants (44% female and 56% male; mean [SD] age at diagnosis, 7.3 [5.6] years), conditional life expectancy was 48.5 years (95% uncertainty interval [UI], 47.6-49.6 years) for 5-year survivors diagnosed in [1970][1971][1972][1973][1974][1975][1976][1977][1978][1979] 53.7 years (95% UI, 52.6-54.7 years) for those diagnosed in 1980-1989, and 57.1 years (95% UI, 55.9-58.1 years) for those diagnosed in 1990-1999. Compared with individuals without a history of cancer, these results represented a gap in life expectancy of 25% (95% UI, 24%-27%) (16.5 years [95% UI, 15.5-17.5 years]) for those diagnosed in 1970-1979 years]) for those diagnosed in 1980-1989, and 14% (95% UI, 13%-16%) (9.2 years [95% UI, 8.3-10.4 years]) for those diagnosed in 1990-1999. During the 3 decades, the proportion of survivors treated with chemotherapy alone increased (from 18% in 1970-1979 to 54% in 1990-1999), and the life expectancy gap in this chemotherapy-alone group decreased from 11.0 years (95% UI, 9.0-13.1 years) to 6.0 years (95% UI, 4.5-7.6 years). In contrast, during the same time frame, only modest improvements in the gap in life expectancy were projected for survivors treated with radiotherapy (21.0 years [95% UI, 18.5-23.2 years] to 17.6 years [95% UI, 14.2-21.2 years]) or with radiotherapy and chemotherapy (17.9 years [95% UI, 16.7-19.2 years] to 14.8 years [95% UI, 13.1-16.7 years]). For the largest group of survivors by diagnosis-those with acute lymphoblastic leukemia-the gap in life expectancy decreased from 14.7 years (95% UI, 12.8-16.5 years) in 1970-1979 to...

Technology-Assisted Psychosocial Interventions for Childhood, Adolescent, and Young Adult Cancer Survivors: A Systematic Review and Meta-Analysis

“…2,3 Advances in the therapeutic and supportive care have improved the overall 5-year cancer survival rate among children and AYAs to 80% or higher, 4,5 which has resulted in a large and growing population of childhood and AYA cancer survivors. 6,7 As the prognosis for childhood and AYA cancer patients continues to improve, increased attention has been focused on the health-related quality of life (HRQoL), including psychosocial, behavioral, and functional health, among members of this population. 8,9 Indeed, studies have reported that over 60% of childhood and AYA cancer survivors experience adverse psychosocial, behavioral, and functional health outcomes that compromise their HRQoL for many years after completion of cancer treatment.…”

Fear of cancer recurrence in childhood cancer survivors: A developmental perspective from infancy to young adulthood

“…However, research on FCR to date has focused almost exclusively on adult populations, with some recent consideration of adolescent or young adult survivors but with the majority of study participants diagnosed or currently over 18 years of age 5‐7 . Yet, children with cancer are more likely to survive their disease compared to adults, and due to therapeutic advancements, more children and adolescents are surviving cancer than ever before 8 . Unfortunately, many childhood cancer survivors will become regular and lifelong users of the medical system to mitigate the late effects of toxic treatments.…”

Pediatric sarcoma survivorship: A call for a developmental cascades approach

“…Researchers and clinicians have long recognized "late effects"or negative physical and psychosocial outcomesin childhood cancer survivors (e.g., Byrd, 1985;Mulhern, 1994). The consequences of intensive therapies and these late effects have been shown to lower the life expectancy of childhood cancer survivors (Yeh et al, 2020), particularly that of Ewing sarcoma survivors (Yeh, Nekhlyudov, Goldie, Mertens, & Diller, 2010). A developmental cascades approach offers a way of thinking about mechanisms involved in such late effects and their cumulative impact.…”